Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(7 sites)
United States
Mayo Clinic - Arizona, Phoenix, Arizona Stanford University Medical Center, Palo Alto, California Moffitt Cancer Center, Tampa, Florida Dana-Farber Cancer Institute, Boston, Massachusetts University of Michigan, Ann Arbor, Michigan Memorial Sloan Kettering Cancer Center, New York, New York University of Utah Health, Salt Lake City, Utah